Aurobindo Pharma continues good show; scrip hits 52-week high

Aurobindo Pharma continues good show; scrip hits 52-week high
Shares of drug maker Aurobindo Pharma extended gain over 5 per cent in early trade on Bombay Stock Exchange (BSE) with the stock touching 52-week high as investors continued to bet on companies robust performance.

The company had reported a robust operating performance for the second quarter ended September 2013 and had also received the final approval from the U.S. health regulator to manufacture and market DuloxetineHydrochloride Delayed-Release capsules, an anti-depressant drug, in the American market.

Continuing its gaining momentum, shares of company gained as much as 5.47 per cent to trade at Rs 404.80 a piece on the BSE.

In a similar fashion, shares of the company advanced 4.43 per cent 400.80 a piece on National Stock Exchange.

Meanwhile, the broader benchmark Sensex was quoting at 21,124.39, down 23.36 points or 0.11 per cent at 10:12 hours.

Dion Global Solutions Ltd.

Story first published: Tuesday, December 24, 2013, 12:44 [IST]
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?